Now that the festive season has finished its back to work with a vengeance.  Let's remind ourselves about what the dynamic duo had to say on 20 November 1919 at the CC broadcast.

Suresh Venkatesen

Given my background in semiconductor and process technology and Vivek’s history in the optical industry, we contribute a unique combination of strategic, technical, and operational execution expertise in both photonics and semiconductors. As a result, I believe POET will benefit from a further refined go-to-market strategy and expanded strategic customer engagements that will ultimately drive accelerated commercialization and adoption of our interposer platform

Vivek Rajgarhia

Following the divestiture of DenseLight the company could still be considered early-stage in terms of achieving full commercialization and revenue yet, at the same time, it has several huge advantages compared to most early-stage opportunities. 

1.  The company is in the final validation phase of commercializing a new technology platform. 

1.  POET has, and is actively working with, a lead tier-one strategic networking customer. 

1. The technology is poised to be highly disruptive in the data-center and 5G markets. 

1.  It’s providing a wafer-level integration platform (that’s?) a game-changer and expandable to other applications such as IoT and LIDAR. 

1.  And: strength and expertise of the existing team.

The appointment of VR I feel must be seen as a change step in POET strategy.  The above statements takes the company beyond the  immediate concerns of payment tranches for the sale of DensLight and the testing of the 8th component of the OI platform to a 'Go to Market' strategy.  SV also uses the term 'accelerated commercialisation'.  Such engagement I presume will be focussed at other Tier One customers other than Customer One, who will by now I hope be eagerly unpacking a OI product designed to their specification for in house testing.  Given the round of briefings in Nov/Dec I expect that progress on the Go to Market Stategy will be reported in final quarter/end of FY year papers.  

I take a lot of comfort from the fact that both the Chinese Consortiun buying DL and the arrival of VR means that a significant amount of Due Diligence has been carried out along with careful examination of the Business Potential of POET Technologies inc to get the tick of approval that preparation for 'accelerated commercialisation'.  This means that shareholder value built into PTK is high and the argument to convince new and commercial investors in the company must have a higher order opportunity than ever before.  This has silenced the 'they've got nothing Brigade' for the moment and surely those in deep need for realistic appraisal rather than Hope must be moved out to some extent from their normal gloom.

I have a sense that the jointism that must have gone on with Customer One must place this customer in an advantageous position in the market given the ' highly disruptive' label that someone as active in the photonics industry as VR states must lead to a greater interest in the POET OI as the 'go to market' efforts evolve.

Ultimately it will be sales orders that will propel the PTK SP into different orders of magnitude, that will be second half of 2020, but I see no reason why commercial investment interest cannot be stimulated sooner given the growing interest in investing Companies that are  involved in the 5g explosion being more and more pumped  by investment adverts, certainly here in the UK.

sula